Recent Finacing
Recent Raise
Connect Biopharma is a clinical-stage company using a T‑cell–based Immune Modulation Technology Platform to discover monoclonal antibodies and S1P1 modulators (CBP‑201, CBP‑307) for autoimmune and inflammatory diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Connect Biopharmaceuticals.
